martes, 16 de enero de 2018

Health News and Information - News Medical :: Parkinson's Disease - Jan 15, 2018 Edition

January 15, 2018
Parkinson's Disease
The latest Parkinson's disease news from News Medical
Testing blood for caffeine levels may aid diagnosis of Parkinson's diseaseTesting blood for caffeine levels may aid diagnosis of Parkinson's disease
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Study finds new brainstem changes in Parkinson’s diseaseStudy finds new brainstem changes in Parkinson’s disease
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.
Pfizer to stop Alzheimer’s and Parkinson’s disease researchPfizer to stop Alzheimer’s and Parkinson’s disease research
Pharmaceutical giant Pfizer has announced its intention to stop research and development in areas including Alzheimer’s disease and Parkinson’s disease.
Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s diseaseSynergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease
Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.
Study finds overall pattern of commonality between Huntington's and Parkinson's
Study finds overall pattern of commonality between Huntington's and Parkinson'sA new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases.
Mount Sinai study uncovers potential link between Crohn's and Parkinson's in Jewish population
Mount Sinai study uncovers potential link between Crohn's and Parkinson's in Jewish populationMount Sinai Researchers have just discovered that patients in the Ashkenazi Jewish population with Crohn's disease (a chronic inflammatory of the digestive system) are more likely to carry the LRRK2 gene mutation.

No hay comentarios:

Publicar un comentario